Tony Coles, former Onyx Pharmaceuticals CEO, joins CNBC's Bertha Coombs at the Forbes Healthcare conference to discuss the government shutdown's impact on health care and Obamacare.» Read More
Aug 24- Amgen Inc is close to buying Onyx Pharmaceuticals Inc for $125 per share, or more than $10 billion, in a deal that is expected to be announced as soon as Monday, two people familiar with the matter said on Saturday.
Some of the names on the move ahead of the open.
NEW YORK, Aug 21- Onyx Pharmaceuticals Inc has given potential buyers, including Amgen Inc, access to trial data on its new cancer drug, removing a key hurdle that was holding up deal talks, according to three people familiar with the matter.
*Priceline gains on results, headed towards $1,000 a share. "We're in a very slow month, and profit taking is coming back into the market," said Adam Hewison, president and chief executive at INO Inc in Annapolis, Maryland. "
Companies are making headlines before the bell on Friday include:
*Priceline gains on results, headed towards $1,000 a share. NEW YORK, Aug 9- U.S. stock index futures were lower on Friday, putting major indexes on track for their worst week since June, as investors found few reasons buy with equity prices near record levels.
Onyx had previously rejected an unsolicited takeover offer from Amgen Inc as being too low.
NEW YORK, Aug 7- Onyx Pharmaceuticals Inc is close to selling itself to larger rival Amgen Inc as the cancer drugmaker's high stock price has discouraged other companies from making a counteroffer so far, according to three people familiar with the matter.
NEW YORK, Aug 7- Onyx Pharmaceuticals Inc is close to selling itself to larger rival Amgen Inc after the cancer drugmaker's high stock price discouraged other companies from making a counter offer, according to three people familiar with the matter.
Check out which companies are making headlines after the bell Thursday:
July 30- Amgen Inc, which is attempting to buy Onyx Pharmaceuticals Inc to add to its cancer drug offerings, on Tuesday reported higher-than-expected second- quarter profit as sales of many of its drugs rebounded from a disappointing first quarter.
*Trader calls SEC view "oversimplified and unsophisticated". Dhia Jafar and Omar Nabulsi, both of Dubai, said a court-ordered freeze should be lifted on the $2.53 million profit that they made lawfully from buying Onyx call options in the last week of June, according to filings late Tuesday in U.S. District Court in Manhattan.
*Traders call SEC view "oversimplified and unsophisticated". NEW YORK, July 24- Two previously unnamed defendants have come forward in a U.S. Securities and Exchange Commission civil lawsuit over alleged insider trading in Onyx Pharmaceuticals Inc while the company was mulling a takeover bid, and said they did nothing wrong.
NEW YORK, July 18- Pfizer Inc decided not to pursue a bid for Onyx Pharmaceuticals Inc this week, according to two people familiar with the matter, leaving Amgen Inc in the front position to buy the cancer drugmaker.
Pharmaceutical and biotech stocks have outperformed markets this year, and with J&J's second-quarter earnings beat, investors may hope earnings will push stocks even higher.
Stocks closed lower Tuesday, with the S&P 500 breaking an 8-day rally, following a mixed batch of economic and earnings reports and as investors hesitated to jump in ahead of Fed Chairman Ben Bernanke's congressional testimony.
NEW YORK, July 16- Onyx Pharmaceuticals Inc is expected to receive initial takeover bids as soon as this week after attracting interest from a few drugmakers, including Amgen Inc, according to several people familiar with the matter.
NEW YORK/ LOS ANGELES, July 12- Swiss drugmaker Roche Holding AG is seeking financing for a potential bid for Alexion Pharmaceuticals Inc, a transaction that if successful would be the largest healthcare deal of the year, two people familiar with the matter said on Friday.
*Investors watching situation in Egypt for oil impact. NEW YORK, July 5- U.S. stock index futures pointed to gains of more than 1 percent at the open on Friday as June payrolls data was much stronger than expected.
NEW YORK, July 5- U.S. stock index futures jumped on Friday as investors looked ahead to a monthly payrolls report that was expected to show solid jobs growth while not being strong enough to influence Federal Reserve policy.